hnRNP D-Like Protein

hnRNP D-Like Protein

Overview

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">hnRNP D-Like Protein</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>HNRNPDL</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>hnRNP D-Like</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Protein</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/?query=HNRNPDL" target="_blank">Search UniProt</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

Hnrnp D Like Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Introduction

hnRNP D-Like Protein

Overview

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">hnRNP D-Like Protein</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>HNRNPDL</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>hnRNP D-Like</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Protein</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/?query=HNRNPDL" target="_blank">Search UniProt</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

Hnrnp D Like Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Introduction

HNRNPDL (Heterogeneous Nuclear Ribonucleoprotein D-Like) is an RNA-binding protein that plays critical roles in post-transcriptional gene regulation[@gratacs2020]. Also known as HNRPDL or JPOX, this protein belongs to the hnRNP D family, which includes hnRNP D (AUF1), hnRNP DL, and related proteins. HNRNPDL contains two RNA recognition motifs (RRMs) that enable it to bind to specific RNA sequences and regulate mRNA stability, alternative splicing, and translation[@yoon2019]. Mutations in HNRNPDL cause limb-girdle muscular dystrophy type 1G (LGMD1G), and the protein has been implicated in the pathogenesis of amyotrophic lateral sclerosis (ALS) and other neurodegenerative disorders[@evangelista2019].

Gene and Protein Structure

Gene Organization

The HNRNPDL gene is located on chromosome 4p15 and spans approximately 13 kb of genomic DNA. It consists of 13 exons that undergo alternative splicing to produce multiple protein isoforms:

• Exon structure: Alternative splicing generates variants with different C-terminal regions
• Promoter: Contains GC-rich elements and potential binding sites for transcriptional regulators
• Expression: Ubiquitously expressed with highest levels in heart, skeletal muscle, and brain

Protein Architecture

HNRNPDL (420 aa, 46.5 kDa) contains several functional domains:

RNA Recognition Motifs (RRMs)

• RRM1 (aa 131-210): Recognizes U-rich and AU-rich elements (AREs)
• RRM2 (aa 226-303): Facilitates RNA binding and protein interactions
• RGG box: Arginine-glycine-glycine rich region involved in RNA binding
• Q-rich domain: Glutamine-rich region for protein-protein interactions

• Phosphorylation: Serine/threonine phosphorylation regulates localization
• Sumoylation: Modulates transcriptional activity
• Acetylation: Affects protein-protein interactions

Normal Cellular Functions

mRNA Stability Regulation

HNRNPDL regulates mRNA half-life through:

Alternative Splicing

The protein modulates splicing patterns by:

• Binding to exonic/intronic splicing regulatory elements
• Interacting with spliceosome components (U1, U2, U4/U6.U5)
• Regulating tissue-specific splicing programs

Transcriptional Regulation

• Transcriptional co-activator: Interacts with p300/CBP
• Chromatin association: May regulate transcription elongation
• Nuclear-cytoplasmic shuttling: Dynamic localization during stress

Circadian Rhythm Control

HNRNPDL contributes to circadian timing by:

• Regulating stability of clock gene transcripts (PER, CRY)
• Coupling circadian output to metabolic pathways
• Responding to light/dark transitions

Role in Neurodegenerative Diseases

Amyotrophic Lateral Sclerosis (ALS)

Evidence for involvement:

• HNRNPDL aggregates found in ALS patient motor [neurons](/entities/neurons)
• Mutations in RNA-binding proteins (FUS, [TDP-43](/proteins/tdp-43), HNRNPA1/A2B1) are ALS causative
• Loss of HNRNPDL leads to splicing dysregulation
• Stress granule formation sequesters HNRNPDL

Limb-Girdle Muscular Dystrophy Type 1G (LGMD1G)

Genetics:

• Autosomal dominant inheritance
• Missense mutations in HNRNPDL (H304R, D262N, L267P)
• Primarily affects proximal muscles

• Muscle fiber degeneration
• Reduced muscle regeneration capacity
• RNA processing defects in muscle cells

Parkinson's Disease

• Altered HNRNPDL expression in PD brains
• RNA metabolism deficits in dopaminergic neurons
• Potential link to [alpha-synuclein](/proteins/alpha-synuclein) pathology

Alzheimer's Disease

• Dysregulated RNA metabolism in AD
• HNRNPDL involvement in [tau](/proteins/tau) exon 10 splicing
• May affect [amyloid precursor protein](/entities/app-protein) (APP) processing

Molecular Interactions

RNA Targets

• Clock genes: PER1, PER2, BMAL1
• Cytokine mRNAs: TNF-α, IL-6
• Muscle-specific transcripts: DMD, ACTA1
• Neuronal transcripts: Synaptic protein mRNAs

Protein Partners

• hnRNP family: hnRNP A1, A2B1, C1/C2
• Spliceosomal proteins: U1-70K, SF3B1
• Transcription factors: Sp1, [NF-κB](/entities/nf-kb)
• Stress granule proteins: G3BP1, TIA-1

Signaling Pathways

• p38 MAPK: Phosphorylates HNRNPDL during stress
• ERK signaling: Regulates nucleocytoplasmic shuttling
• JAK/STAT: Cytokine-mediated HNRNPDL regulation

Therapeutic Implications

RNA-Targeted Therapies

• Antisense oligonucleotides: Correct aberrant splicing
• Small molecule modulators: Enhance HNRNPDL function
• RNA stabilizers: Preserve beneficial transcripts

Gene Therapy Approaches

• AAV-mediated delivery: Express wild-type HNRNPDL
• CRISPR editing: Correct disease-causing mutations
• RNAi knockdown: Reduce toxic aggregates (in specific contexts)

Small Molecule Screening

• Splice-modulating compounds: Target splicing factors
• Stress granule inhibitors: Prevent pathological aggregation
• Neuroprotective agents: Support neuronal survival

Research Methods

Experimental Systems

• Cell lines: HEK293, myoblasts, motor neurons (iPSC-derived)
• Animal models: Transgenic mice, zebrafish models
• Patient tissue: Muscle biopsies, post-mortem brain

Detection Techniques

• RIP-seq: Map HNRNPDL RNA targets
• CLIP-seq: Identify protein-RNA interactions
• Mass spectrometry: Identify protein partners
• Live cell imaging: Track subcellular localization

Overview

Hnrnp D Like Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Background

The study of Hnrnp D Like Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

See Also

• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Amyloid Hypothesis](/mechanisms/amyloid-hypothesis)
• [Tau Pathology](/mechanisms/tau-pathology)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Alpha-Synuclein](/mechanisms/alpha-synuclein)

External Links

• [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
• [Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
• [Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data

Cross-References

• [HNRNPDL Gene](/proteins/hnrnpdl-protein)
• [ALS Disease](/diseases/amyotrophic-lateral-sclerosis-als)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [RNA Metabolism](/mechanisms/rna-metabolism)
• [Stress Granules](/mechanisms/stress-granules)
• [Muscular Dystrophy](/diseases/muscular-dystrophy)
• [Proteins Index](/proteins)

References